Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK

Introduction: Malignant spinal cord compression (MSCC) is one of the most devastating complications of cancer. This event requires rapid decision-making on the part of several specialists, given the risk of permanent spinal cord injury or death. The goals of treatment in spinal metastases are pain c...

Full description

Bibliographic Details
Main Authors: Sidrah Shah, Mikolaj Kutka, Kathryn Lees, Charlotte Abson, Maher Hadaki, Deirdre Cooke, Cherie Neill, Matin Sheriff, Afroditi Karathanasi, Stergios Boussios
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/2/110
_version_ 1797412528198778880
author Sidrah Shah
Mikolaj Kutka
Kathryn Lees
Charlotte Abson
Maher Hadaki
Deirdre Cooke
Cherie Neill
Matin Sheriff
Afroditi Karathanasi
Stergios Boussios
author_facet Sidrah Shah
Mikolaj Kutka
Kathryn Lees
Charlotte Abson
Maher Hadaki
Deirdre Cooke
Cherie Neill
Matin Sheriff
Afroditi Karathanasi
Stergios Boussios
author_sort Sidrah Shah
collection DOAJ
description Introduction: Malignant spinal cord compression (MSCC) is one of the most devastating complications of cancer. This event requires rapid decision-making on the part of several specialists, given the risk of permanent spinal cord injury or death. The goals of treatment in spinal metastases are pain control and improvement of neurological function. There can be challenges in delivering prompt diagnosis and treatment in a secondary care setting. We have reflected on the experience of managing MSCC in a district general setting. Aim: Our retrospective audit identified 53 patients with suspected MSCC who entered the relevant pathway from April 2017 to March 2018 at Medway, United Kingdom (UK). Our audit standards were set out by Medway Maritime Hospital and Maidstone and Tunbridge Wells NHS Trust MSCC working group members, using a combination of published evidence and best practice. Results: The patients with suspected MSCC were 53 and 29 of them (54.7%) had confirmed MSCC. The most common malignancies within the confirmed MSCC were lung (11 patients, 37.9%), breast (5 patients 17.2%), and renal (3 patients, 10.3%), followed by prostate, myeloma and carcinoma of unknown primary (2 patients (6.9%) each), as well as pancreatic, colorectal, lymphoma and, bladder (1 patient (3.4%) each). A magnetic resonance imaging (MRI) scan was performed in 48 patients (90.5%); the majority (31 patients, 64.6%) underwent the MRI within the first 24 h, whereas 3 patients had the investigation between 24 and 72 h from the admission. Among the 29 patients with confirmed MSCC, 6 (20.6%) were treated with surgical decompression, while 20 (69%) received radiotherapy (RT) and 3 (10.3%) best supportive care, respectively. Median time to surgery was 5 days (ranged between 2 and 8 days), whereas for RT 44.4 h (ranged between 24 and 72 h). Finally, all 3 patients that decided on symptom control were referred to a palliative care team within the first 24 h following the MRI scan. Conclusions: MSCC is frequently presented outside tertiary care. This may cause subsequent delays in investigation, diagnosis, and treatment, which can be improved by following a fast track referral pathway.
first_indexed 2024-03-09T05:04:08Z
format Article
id doaj.art-804e9a84dd894d889b75389fd2db78a1
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T05:04:08Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-804e9a84dd894d889b75389fd2db78a12023-12-03T12:57:12ZengMDPI AGJournal of Personalized Medicine2075-44262021-02-0111211010.3390/jpm11020110Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UKSidrah Shah0Mikolaj Kutka1Kathryn Lees2Charlotte Abson3Maher Hadaki4Deirdre Cooke5Cherie Neill6Matin Sheriff7Afroditi Karathanasi8Stergios Boussios9Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKKent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone ME16 9QQ, Kent, UKKent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone ME16 9QQ, Kent, UKKent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone ME16 9QQ, Kent, UKDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKDepartment of Urology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UKIntroduction: Malignant spinal cord compression (MSCC) is one of the most devastating complications of cancer. This event requires rapid decision-making on the part of several specialists, given the risk of permanent spinal cord injury or death. The goals of treatment in spinal metastases are pain control and improvement of neurological function. There can be challenges in delivering prompt diagnosis and treatment in a secondary care setting. We have reflected on the experience of managing MSCC in a district general setting. Aim: Our retrospective audit identified 53 patients with suspected MSCC who entered the relevant pathway from April 2017 to March 2018 at Medway, United Kingdom (UK). Our audit standards were set out by Medway Maritime Hospital and Maidstone and Tunbridge Wells NHS Trust MSCC working group members, using a combination of published evidence and best practice. Results: The patients with suspected MSCC were 53 and 29 of them (54.7%) had confirmed MSCC. The most common malignancies within the confirmed MSCC were lung (11 patients, 37.9%), breast (5 patients 17.2%), and renal (3 patients, 10.3%), followed by prostate, myeloma and carcinoma of unknown primary (2 patients (6.9%) each), as well as pancreatic, colorectal, lymphoma and, bladder (1 patient (3.4%) each). A magnetic resonance imaging (MRI) scan was performed in 48 patients (90.5%); the majority (31 patients, 64.6%) underwent the MRI within the first 24 h, whereas 3 patients had the investigation between 24 and 72 h from the admission. Among the 29 patients with confirmed MSCC, 6 (20.6%) were treated with surgical decompression, while 20 (69%) received radiotherapy (RT) and 3 (10.3%) best supportive care, respectively. Median time to surgery was 5 days (ranged between 2 and 8 days), whereas for RT 44.4 h (ranged between 24 and 72 h). Finally, all 3 patients that decided on symptom control were referred to a palliative care team within the first 24 h following the MRI scan. Conclusions: MSCC is frequently presented outside tertiary care. This may cause subsequent delays in investigation, diagnosis, and treatment, which can be improved by following a fast track referral pathway.https://www.mdpi.com/2075-4426/11/2/110metastatic spinal cord compressioncorticosteroidsdecompressive surgerypalliative radiotherapypathway
spellingShingle Sidrah Shah
Mikolaj Kutka
Kathryn Lees
Charlotte Abson
Maher Hadaki
Deirdre Cooke
Cherie Neill
Matin Sheriff
Afroditi Karathanasi
Stergios Boussios
Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
Journal of Personalized Medicine
metastatic spinal cord compression
corticosteroids
decompressive surgery
palliative radiotherapy
pathway
title Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
title_full Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
title_fullStr Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
title_full_unstemmed Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
title_short Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
title_sort management of metastatic spinal cord compression in secondary care a practice reflection from medway maritime hospital kent uk
topic metastatic spinal cord compression
corticosteroids
decompressive surgery
palliative radiotherapy
pathway
url https://www.mdpi.com/2075-4426/11/2/110
work_keys_str_mv AT sidrahshah managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT mikolajkutka managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT kathrynlees managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT charlotteabson managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT maherhadaki managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT deirdrecooke managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT cherieneill managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT matinsheriff managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT afroditikarathanasi managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk
AT stergiosboussios managementofmetastaticspinalcordcompressioninsecondarycareapracticereflectionfrommedwaymaritimehospitalkentuk